GeneBioTech Co. ,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8,736	9,587	10,279	8,751	7,430	7,430
Short-Term Investments	17,765	15,310	13,125	13,265	8,660	10,360
Cash & Short-Term Investments	26,501	24,897	23,404	22,016	16,090	17,790
Cash Growth	19.37%	6.38%	6.31%	36.83%	-9.56%	-35.04%
Accounts Receivable	14,470	12,388	13,364	11,588	14,090	10,225
Other Receivables	893.19	265.33	356.36	180.69	183.82	74.85
Receivables	15,692	12,982	14,053	11,818	14,302	10,371
Inventory	15,143	14,074	17,041	14,802	15,452	13,676
Prepaid Expenses	17.48	27.39	27.27	24.16	25.66	41.05
Other Current Assets	1,861	2,730	1,310	621.38	399.76	298.05
Total Current Assets	59,215	54,711	55,836	49,281	46,269	42,175
Property, Plant & Equipment	17,089	16,972	13,924	14,159	14,615	14,900
Long-Term Investments	1,539	2,406	639.43	718.86	484.19	763.6
Goodwill	-	-	-	-	589.54	589.54
Other Intangible Assets	565.91	582.66	648.82	632.02	398.29	199.07
Long-Term Deferred Tax Assets	65.84	71.12	66.76	205.29	495.41	870.49
Other Long-Term Assets	593.77	493.18	436.81	513	666.71	294.23
Total Assets	79,461	75,634	71,988	66,017	64,041	60,368
Accounts Payable	5,140	3,654	3,366	3,540	3,901	4,752
Accrued Expenses	1,297	1,160	1,077	970.5	649.23	515.74
Short-Term Debt	9,579	8,109	10,851	7,704	9,486	8,042
Current Portion of Long-Term Debt	2,129	1,924	2,359	1,534	1,159	-
Current Portion of Leases	73.68	76.19	95.17	132.92	42.29	112.39
Current Income Taxes Payable	313.3	413.78	278.37	284.27	14.46	-
Other Current Liabilities	1,109	377.37	337.78	347.33	667.94	716.5
Total Current Liabilities	19,641	15,715	18,364	14,513	15,920	14,139
Long-Term Debt	4,577	4,782	2,466	2,995	2,329	2,113
Long-Term Leases	73.21	66.38	113.47	135.08	12.35	33.57
Other Long-Term Liabilities	74.68	74.68	72.07	68.54	53.02	137
Total Liabilities	24,366	20,638	21,016	17,712	18,315	16,423
Common Stock	4,305	4,305	4,305	4,305	4,305	4,305
Additional Paid-In Capital	14,576	14,576	14,576	14,576	14,576	14,489
Retained Earnings	36,004	35,889	31,803	29,059	18,116	16,190
Comprehensive Income & Other	209.74	225.65	288.42	364.07	8,729	8,961
Total Common Equity	55,095	54,996	50,972	48,305	45,726	43,945
Shareholders' Equity	55,095	54,996	50,972	48,305	45,726	43,945
Total Liabilities & Equity	79,461	75,634	71,988	66,017	64,041	60,368
Total Debt	16,432	14,957	15,885	12,502	13,029	10,302
Net Cash (Debt)	10,069	9,940	7,519	9,514	3,061	7,488
Net Cash Growth	50.94%	32.20%	-20.97%	210.80%	-59.12%	-65.62%
Net Cash Per Share	1170.62	1154.38	873.87	1104.91	355.50	869.68
Filing Date Shares Outstanding	8.56	8.61	8.61	8.61	8.61	8.61
Total Common Shares Outstanding	8.56	8.61	8.61	8.61	8.61	8.61
Working Capital	39,574	38,996	37,472	34,768	30,349	28,037
Book Value Per Share	6436.03	6387.01	5919.73	5609.93	5310.44	5103.62
Tangible Book Value	54,529	54,413	50,323	47,673	44,738	43,157
Tangible Book Value Per Share	6369.92	6319.35	5844.37	5536.52	5195.72	5012.04
Land	7,011	7,011	7,011	7,061	5,464	5,464
Buildings	10,984	10,084	6,452	6,533	6,489	6,471
Machinery	10,095	10,097	9,547	9,342	9,255	9,222
Construction In Progress	-	540	595.13	41.65	1,620	1,007